packageAzacitidine

azacitidine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Azacitidine is an anticancer antimetabolite used to treat blood cancers such as myelodysplastic syndrome, acute myeloid leukemia, and chronic myelomonocytic leukemia. It is approved and authorised in the European Union, with several authorised products, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q416451 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:azacitidine
ATC codes:L01BC07
DrugBank:DB00928
PubChem CID:9444
ChEBI:2038
Wikidata:Q416451
formula:C8H12N4O5
molar mass:244.207 g/mol (PubChem CID 9444)
logP:-2.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown